HIGHFDA DRUG

Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,...

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
June 29, 2026
Status
ACTIVE

Quick Facts at a Glance

Recall Date
June 29, 2026
Hazard Level
HIGH
Brands
CINACALCET, Cipla USA Inc.
Geographic Scope
1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CINACALCET, Cipla USA Inc.
Model numbers
Lot #: 5PB0465, 5PB0466, 5PB0557, Exp 4/30/2027, 5PB0629, 5PB0630, 5PB0633, 5PB0637 +2 more
UPC codes
69097-410, 69097-411, 69097-412, 69097-410-02, 69097-411-02, 69097-412-02
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    June 29, 2026

  2. Reported by FDA DRUG

    July 8, 2026

  3. RecallRadar source check

    July 14, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for CINACALCET recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-410-02. Generic: CINACALCET; Brand: CINACALCET. Reason: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).. Classification: Class II. Quantity: 31,824 bottles. Distribution: USA Nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot #: 5PB0465
5PB0466
5PB0557
Exp 4/30/2027
5PB0629
+5 more
UPC Codes
69097-410
69097-411
69097-412
+3 more
Affected States
ALL
Report Date
July 8, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls